CME Group (NASDAQ:CME) Upgraded to Buy by Goldman Sachs Group

CME Group (NASDAQ:CME) was upgraded by stock analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a report released on Wednesday, February 7th, MarketBeat Ratings reports. The brokerage presently has a $180.00 price target on the financial services provider’s stock. Goldman Sachs Group’s target price points to a potential upside of 12.51% from the company’s previous close.

CME has been the subject of a number of other research reports. Citigroup raised their price objective on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Barclays increased their target price on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Sandler O’Neill restated a “buy” rating and issued a $175.00 price objective on shares of CME Group in a research report on Friday, February 2nd. BidaskClub lowered shares of CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 18th. Finally, Bank of America lifted their target price on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $157.00.

CME Group (CME) traded down $0.18 during trading hours on Wednesday, hitting $159.98. 146,248 shares of the stock were exchanged, compared to its average volume of 1,657,730. The company has a market cap of $54,302.48, a price-to-earnings ratio of 13.40, a P/E/G ratio of 2.10 and a beta of 0.64. CME Group has a 12 month low of $114.82 and a 12 month high of $163.00. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.05 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. During the same period in the prior year, the firm earned $1.14 earnings per share. CME Group’s revenue was down 1.4% on a year-over-year basis. equities analysts expect that CME Group will post 6.26 EPS for the current year.

In other news, insider Sunil Cutinho sold 2,600 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $139.57, for a total transaction of $362,882.00. Following the completion of the sale, the insider now owns 22,301 shares of the company’s stock, valued at approximately $3,112,550.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Terrence A. Duffy sold 20,000 shares of the stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $151.66, for a total transaction of $3,033,200.00. Following the completion of the sale, the chairman now directly owns 99,239 shares of the company’s stock, valued at $15,050,586.74. The disclosure for this sale can be found here. In the last quarter, insiders sold 67,128 shares of company stock worth $10,086,157. 0.57% of the stock is currently owned by company insiders.

A number of hedge funds have recently bought and sold shares of the business. ARK Investment Management LLC purchased a new stake in CME Group during the 4th quarter valued at $120,000. Valeo Financial Advisors LLC purchased a new stake in CME Group in the third quarter worth $124,000. Quadrant Capital Group LLC increased its stake in CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after purchasing an additional 113 shares during the period. AlphaOne Investment Services LLC purchased a new stake in CME Group in the fourth quarter worth $146,000. Finally, Mosaic Family Wealth LLC purchased a new stake in CME Group in the fourth quarter worth $146,000. Institutional investors and hedge funds own 82.85% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/goldman-sachs-group-upgrades-cme-group-cme-to-buy.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply